drugset
drugset / Trial / NCT00266344

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

NCT00266344 ↗

Phase 2 Completed 520 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Timeline

Start
2005-11
Primary completion
—
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule — —

Indications

insomnia